Clinical trial
Study of Dexamethasone in Neonatal Lupus Congenital Heart Block; PRIDE (PR Interval and Dexamethasone Evaluation) in Congenital Heart Block
NCT00007358 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Dexamethasone in Neonatal Lupus Congenital Heart Block; PRIDE (PR Interval and Dexamethasone Evaluation) in Congenital Heart Block
- Lead sponsor
- NYU Langone Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2000
- Completion date
- October 31, 2008
- Enrollment
- 150 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
atrioventricular nodal dysfunction, congenital heart block, myocardial injury, neonatal lupus